GE HealthCare Technologies Inc. Common Stock (GEHC) is a publicly traded Healthcare sector company. As of May 20, 2026, GEHC trades at $64.16 with a market cap of $27.98B and a P/E ratio of 15.35. GEHC moved +4.35% today. Year to date, GEHC is -24.44%; over the trailing twelve months it is -10.56%. Its 52-week range spans $57.65 to $94.80. Analyst consensus is buy with an average price target of $82.36. Rallies surfaces GEHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ventripoint Files AI Cardiac Imaging to NMPA, Exhibits at AEPC Congress: Lishman Global filed Ventripoint’s VMS+ 4.0 AI cardiac imaging system to China’s NMPA on April 28, 2026, seeking expedited approval for 330 million cardiovascular patients. On May 12–16, Ventripoint exhibited VMS+ 4.0 at the AEPC congress in Padua, demonstrating point-of-care MRI-equivalent volumetric assessments.
| Metric | Value |
|---|---|
| Price | $64.16 |
| Market Cap | $27.98B |
| P/E Ratio | 15.35 |
| EPS | $4.18 |
| Dividend Yield | 0.04% |
| 52-Week High | $94.80 |
| 52-Week Low | $57.65 |
| Volume | 6.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $20.98B |
| Net Income | $1.98B |
| Gross Margin | 39.15% |
12 analysts cover GEHC: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.36.